

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lens fiber cell development (GO:0070307) | 9.73385886 |
| 2 | lung epithelium development (GO:0060428) | 9.61474894 |
| 3 | metanephric tubule development (GO:0072170) | 8.59435822 |
| 4 | metanephric nephron tubule development (GO:0072234) | 8.59435822 |
| 5 | kidney morphogenesis (GO:0060993) | 8.54496857 |
| 6 | collecting duct development (GO:0072044) | 8.38663728 |
| 7 | lung-associated mesenchyme development (GO:0060484) | 8.06520737 |
| 8 | cartilage morphogenesis (GO:0060536) | 7.84642664 |
| 9 | metanephric nephron epithelium development (GO:0072243) | 7.72090029 |
| 10 | metanephric epithelium development (GO:0072207) | 7.22062815 |
| 11 | anatomical structure regression (GO:0060033) | 6.98759157 |
| 12 | lung morphogenesis (GO:0060425) | 6.49567374 |
| 13 | DNA ligation (GO:0006266) | 5.39317395 |
| 14 | DNA deamination (GO:0045006) | 5.29595728 |
| 15 | cytidine metabolic process (GO:0046087) | 5.06990397 |
| 16 | cytidine catabolic process (GO:0006216) | 5.06990397 |
| 17 | cytidine deamination (GO:0009972) | 5.06990397 |
| 18 | nephron tubule development (GO:0072080) | 5.03336798 |
| 19 | T cell migration (GO:0072678) | 4.85047106 |
| 20 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.76915580 |
| 21 | renal tubule development (GO:0061326) | 4.46713843 |
| 22 | base-excision repair, AP site formation (GO:0006285) | 4.45850055 |
| 23 | apoptotic process involved in morphogenesis (GO:0060561) | 4.45444471 |
| 24 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.33413573 |
| 25 | nephron epithelium development (GO:0072009) | 4.04157195 |
| 26 | nonmotile primary cilium assembly (GO:0035058) | 3.97175058 |
| 27 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.86454670 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.83874511 |
| 29 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.82222504 |
| 30 | protein-cofactor linkage (GO:0018065) | 3.77586214 |
| 31 | apoptotic process involved in development (GO:1902742) | 3.63118436 |
| 32 | mismatch repair (GO:0006298) | 3.54292759 |
| 33 | central nervous system myelination (GO:0022010) | 3.45658024 |
| 34 | axon ensheathment in central nervous system (GO:0032291) | 3.45658024 |
| 35 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.43363876 |
| 36 | DNA dealkylation (GO:0035510) | 3.41761471 |
| 37 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.37660713 |
| 38 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.33524929 |
| 39 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.33524929 |
| 40 | developmental programmed cell death (GO:0010623) | 3.26041900 |
| 41 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.22565399 |
| 42 | positive regulation of cell fate commitment (GO:0010455) | 3.20782527 |
| 43 | male meiosis (GO:0007140) | 3.16651130 |
| 44 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.14333577 |
| 45 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.11198290 |
| 46 | regulation of B cell differentiation (GO:0045577) | 3.10037777 |
| 47 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.06071683 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.01011013 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.00585806 |
| 50 | telomere maintenance via recombination (GO:0000722) | 2.97454803 |
| 51 | negative regulation of T cell apoptotic process (GO:0070233) | 2.94791551 |
| 52 | pseudouridine synthesis (GO:0001522) | 2.94672217 |
| 53 | smooth muscle cell differentiation (GO:0051145) | 2.92513929 |
| 54 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.90154195 |
| 55 | Peyers patch development (GO:0048541) | 2.90154195 |
| 56 | regulation of mesoderm development (GO:2000380) | 2.89861116 |
| 57 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.89689032 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83422895 |
| 59 | viral transcription (GO:0019083) | 2.82836081 |
| 60 | deoxyribonucleotide catabolic process (GO:0009264) | 2.81584765 |
| 61 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.80438902 |
| 62 | non-recombinational repair (GO:0000726) | 2.79843068 |
| 63 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.79843068 |
| 64 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.79106163 |
| 65 | lymphocyte migration (GO:0072676) | 2.77527494 |
| 66 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.77108840 |
| 67 | DNA demethylation (GO:0080111) | 2.76391679 |
| 68 | behavioral response to nicotine (GO:0035095) | 2.75790863 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.75602619 |
| 70 | translational termination (GO:0006415) | 2.75521726 |
| 71 | V(D)J recombination (GO:0033151) | 2.74564538 |
| 72 | negative regulation by host of viral transcription (GO:0043922) | 2.74413014 |
| 73 | response to interleukin-15 (GO:0070672) | 2.74064289 |
| 74 | male meiosis I (GO:0007141) | 2.73707754 |
| 75 | ATP synthesis coupled proton transport (GO:0015986) | 2.71206551 |
| 76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.71206551 |
| 77 | lymphocyte chemotaxis (GO:0048247) | 2.71182861 |
| 78 | deoxyribose phosphate catabolic process (GO:0046386) | 2.62631396 |
| 79 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.61526193 |
| 80 | termination of RNA polymerase III transcription (GO:0006386) | 2.61526193 |
| 81 | rRNA catabolic process (GO:0016075) | 2.58324324 |
| 82 | dendritic cell chemotaxis (GO:0002407) | 2.57691312 |
| 83 | protein targeting to ER (GO:0045047) | 2.54370260 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 2.54188615 |
| 85 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.53343625 |
| 86 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.53195424 |
| 87 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.52472904 |
| 88 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.51540982 |
| 89 | dentate gyrus development (GO:0021542) | 2.49875799 |
| 90 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.49795857 |
| 91 | grooming behavior (GO:0007625) | 2.48120520 |
| 92 | cotranslational protein targeting to membrane (GO:0006613) | 2.46026990 |
| 93 | platelet dense granule organization (GO:0060155) | 2.45175865 |
| 94 | ribosomal small subunit biogenesis (GO:0042274) | 2.44937703 |
| 95 | maturation of SSU-rRNA (GO:0030490) | 2.43678008 |
| 96 | base-excision repair (GO:0006284) | 2.42490115 |
| 97 | purine nucleobase biosynthetic process (GO:0009113) | 2.41726010 |
| 98 | DNA strand elongation (GO:0022616) | 2.41624389 |
| 99 | mitotic recombination (GO:0006312) | 2.41155310 |
| 100 | respiratory tube development (GO:0030323) | 11.1656231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 8.76358375 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 8.12037312 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 5.01749963 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.19043883 |
| 5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.89466624 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.74583020 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.90070771 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.81585467 |
| 9 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.52681461 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.39720005 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.34851483 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32352939 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.22764927 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18934753 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18465999 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.13119685 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.05071370 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.02706442 |
| 19 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.93408380 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.90876085 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88950252 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71815905 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70320162 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68809288 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.67994809 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.65981983 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.65879656 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64595065 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60150035 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59004051 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47300181 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44735228 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41102890 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.33095710 |
| 35 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.29153051 |
| 36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27013140 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25833312 |
| 38 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.25349676 |
| 39 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.24414262 |
| 40 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21871061 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18980570 |
| 42 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18867537 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18867008 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15408869 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15317989 |
| 46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14660103 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.12048513 |
| 48 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.11470673 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09259564 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07004445 |
| 51 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06666398 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.06584650 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04821984 |
| 54 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.04552616 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03785642 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02662879 |
| 57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.97674959 |
| 58 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.97633520 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95467416 |
| 60 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.95095257 |
| 61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94277739 |
| 62 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94000214 |
| 63 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93476302 |
| 64 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93476302 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93278963 |
| 66 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93161290 |
| 67 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90542407 |
| 68 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90385086 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90317653 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 0.89845698 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 0.88606896 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86787007 |
| 73 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.86419643 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 0.83839274 |
| 75 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.82963691 |
| 76 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.81839348 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.81359799 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.80975129 |
| 79 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.80497318 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.79820257 |
| 81 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.79496913 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.79307310 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79114070 |
| 84 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78719501 |
| 85 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.77626972 |
| 86 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.76816380 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.75041784 |
| 88 | ERA_21632823_ChIP-Seq_H3396_Human | 0.74428906 |
| 89 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.73559548 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72654487 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.72595992 |
| 92 | P300_27268052_Chip-Seq_Bcells_Human | 0.72489213 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.72024172 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71844821 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.71469452 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.71446301 |
| 97 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.70715733 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.70684258 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68282851 |
| 100 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.67792075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001346_abnormal_lacrimal_gland | 6.86909294 |
| 2 | MP0010030_abnormal_orbit_morphology | 5.64036852 |
| 3 | MP0005646_abnormal_pituitary_gland | 5.19048934 |
| 4 | MP0005248_abnormal_Harderian_gland | 4.39646807 |
| 5 | MP0008057_abnormal_DNA_replication | 4.07910353 |
| 6 | MP0002102_abnormal_ear_morphology | 3.43509354 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.11528903 |
| 8 | MP0002653_abnormal_ependyma_morphology | 2.81583585 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.80738789 |
| 10 | MP0001348_abnormal_lacrimal_gland | 2.42029619 |
| 11 | MP0009278_abnormal_bone_marrow | 2.39311696 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.37654796 |
| 13 | MP0000015_abnormal_ear_pigmentation | 2.31562373 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.21173567 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.18090133 |
| 16 | MP0002163_abnormal_gland_morphology | 2.14642167 |
| 17 | MP0005671_abnormal_response_to | 2.12188565 |
| 18 | MP0009840_abnormal_foam_cell | 2.01033234 |
| 19 | MP0002095_abnormal_skin_pigmentation | 1.75245206 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.65283079 |
| 21 | MP0002938_white_spotting | 1.63380006 |
| 22 | MP0000569_abnormal_digit_pigmentation | 1.63264991 |
| 23 | MP0003283_abnormal_digestive_organ | 1.61696660 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 1.52790139 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.52554283 |
| 26 | MP0009785_altered_susceptibility_to | 1.49317636 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35019439 |
| 28 | MP0008789_abnormal_olfactory_epithelium | 1.32577430 |
| 29 | MP0000685_abnormal_immune_system | 1.30293874 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.28865933 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.28211106 |
| 32 | MP0002295_abnormal_pulmonary_circulatio | 1.27963280 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.26632452 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.25789269 |
| 35 | MP0001984_abnormal_olfaction | 1.24446606 |
| 36 | MP0004147_increased_porphyrin_level | 1.22752691 |
| 37 | MP0005379_endocrine/exocrine_gland_phen | 1.17746751 |
| 38 | MP0001293_anophthalmia | 1.12305614 |
| 39 | MP0004885_abnormal_endolymph | 1.08584697 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.07908430 |
| 41 | MP0001800_abnormal_humoral_immune | 1.06924923 |
| 42 | MP0001663_abnormal_digestive_system | 1.06252772 |
| 43 | MP0003111_abnormal_nucleus_morphology | 1.01112679 |
| 44 | MP0005394_taste/olfaction_phenotype | 0.98790954 |
| 45 | MP0005499_abnormal_olfactory_system | 0.98790954 |
| 46 | MP0005025_abnormal_response_to | 0.97541359 |
| 47 | MP0009697_abnormal_copulation | 0.96301909 |
| 48 | MP0003252_abnormal_bile_duct | 0.95126704 |
| 49 | MP0008007_abnormal_cellular_replicative | 0.94536360 |
| 50 | MP0004742_abnormal_vestibular_system | 0.92289832 |
| 51 | MP0008872_abnormal_physiological_respon | 0.91480810 |
| 52 | MP0006292_abnormal_olfactory_placode | 0.90613688 |
| 53 | MP0002420_abnormal_adaptive_immunity | 0.89353016 |
| 54 | MP0003878_abnormal_ear_physiology | 0.89303941 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 0.89303941 |
| 56 | MP0001545_abnormal_hematopoietic_system | 0.89109597 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 0.89109597 |
| 58 | MP0002166_altered_tumor_susceptibility | 0.89042288 |
| 59 | MP0003632_abnormal_nervous_system | 0.88726093 |
| 60 | MP0003329_amyloid_beta_deposits | 0.86639792 |
| 61 | MP0001819_abnormal_immune_cell | 0.86279430 |
| 62 | MP0002723_abnormal_immune_serum | 0.86169789 |
| 63 | MP0002405_respiratory_system_inflammati | 0.84849211 |
| 64 | MP0005195_abnormal_posterior_eye | 0.84467415 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 0.82977706 |
| 66 | MP0002092_abnormal_eye_morphology | 0.81790056 |
| 67 | MP0005253_abnormal_eye_physiology | 0.81308762 |
| 68 | MP0005197_abnormal_uvea_morphology | 0.81137756 |
| 69 | MP0006082_CNS_inflammation | 0.80334396 |
| 70 | MP0005391_vision/eye_phenotype | 0.79343174 |
| 71 | MP0005387_immune_system_phenotype | 0.78895739 |
| 72 | MP0001790_abnormal_immune_system | 0.78895739 |
| 73 | MP0002006_tumorigenesis | 0.78655616 |
| 74 | MP0005000_abnormal_immune_tolerance | 0.77958079 |
| 75 | MP0003786_premature_aging | 0.77356820 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.76877649 |
| 77 | MP0002398_abnormal_bone_marrow | 0.76792795 |
| 78 | MP0002722_abnormal_immune_system | 0.74075401 |
| 79 | MP0005410_abnormal_fertilization | 0.73715268 |
| 80 | MP0002210_abnormal_sex_determination | 0.73607846 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 0.73033996 |
| 82 | MP0001119_abnormal_female_reproductive | 0.72961604 |
| 83 | MP0003045_fibrosis | 0.72893208 |
| 84 | MP0000026_abnormal_inner_ear | 0.72607745 |
| 85 | MP0000604_amyloidosis | 0.72547907 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.71784671 |
| 87 | MP0002452_abnormal_antigen_presenting | 0.69953321 |
| 88 | MP0003448_altered_tumor_morphology | 0.69790091 |
| 89 | MP0002419_abnormal_innate_immunity | 0.67758993 |
| 90 | MP0000681_abnormal_thyroid_gland | 0.67444650 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.65988069 |
| 92 | MP0002429_abnormal_blood_cell | 0.65981640 |
| 93 | MP0000716_abnormal_immune_system | 0.65414192 |
| 94 | MP0008770_decreased_survivor_rate | 0.65059762 |
| 95 | MP0001324_abnormal_eye_pigmentation | 0.63882444 |
| 96 | MP0001929_abnormal_gametogenesis | 0.63319502 |
| 97 | MP0009384_cardiac_valve_regurgitation | 0.62615441 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.61034583 |
| 99 | MP0010386_abnormal_urinary_bladder | 0.58427625 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.56950979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased central vision (HP:0007663) | 8.96316325 |
| 2 | Dyschromatopsia (HP:0007641) | 6.70784211 |
| 3 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 4.77253632 |
| 4 | True hermaphroditism (HP:0010459) | 4.45586946 |
| 5 | Attenuation of retinal blood vessels (HP:0007843) | 4.09385090 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.96486311 |
| 7 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.86649841 |
| 8 | Mesangial abnormality (HP:0001966) | 3.59507878 |
| 9 | Pendular nystagmus (HP:0012043) | 3.48950794 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 3.41296322 |
| 11 | Aplastic anemia (HP:0001915) | 3.40514015 |
| 12 | Agammaglobulinemia (HP:0004432) | 3.34425870 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.23980109 |
| 14 | Pancreatic fibrosis (HP:0100732) | 3.20587603 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.11524370 |
| 16 | Thyroiditis (HP:0100646) | 2.96533887 |
| 17 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.91545930 |
| 18 | Stomatitis (HP:0010280) | 2.87158181 |
| 19 | Severe combined immunodeficiency (HP:0004430) | 2.79830907 |
| 20 | Severe visual impairment (HP:0001141) | 2.74734212 |
| 21 | Pancreatic cysts (HP:0001737) | 2.71540235 |
| 22 | T lymphocytopenia (HP:0005403) | 2.68861258 |
| 23 | IgG deficiency (HP:0004315) | 2.66280206 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 2.63383241 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 2.60388174 |
| 26 | Keratoconus (HP:0000563) | 2.59743132 |
| 27 | Increased corneal curvature (HP:0100692) | 2.59743132 |
| 28 | Abnormality of T cell number (HP:0011839) | 2.59321667 |
| 29 | Increased CSF lactate (HP:0002490) | 2.58111255 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.57527765 |
| 31 | Hypoplasia of the thymus (HP:0000778) | 2.56795876 |
| 32 | Combined immunodeficiency (HP:0005387) | 2.55274170 |
| 33 | 3-Methylglutaconic aciduria (HP:0003535) | 2.53773768 |
| 34 | Recurrent viral infections (HP:0004429) | 2.49825981 |
| 35 | Abnormal number of erythroid precursors (HP:0012131) | 2.49722684 |
| 36 | Renal cortical cysts (HP:0000803) | 2.47345606 |
| 37 | Mitochondrial inheritance (HP:0001427) | 2.41291664 |
| 38 | Neoplasm of the adrenal cortex (HP:0100641) | 2.40129433 |
| 39 | Abnormality of eosinophils (HP:0001879) | 2.39180655 |
| 40 | Hypoproteinemia (HP:0003075) | 2.35624532 |
| 41 | Sex reversal (HP:0012245) | 2.34466708 |
| 42 | Abnormal sex determination (HP:0012244) | 2.34466708 |
| 43 | Metabolic alkalosis (HP:0200114) | 2.31606174 |
| 44 | Exertional dyspnea (HP:0002875) | 2.30395644 |
| 45 | Abolished electroretinogram (ERG) (HP:0000550) | 2.30355975 |
| 46 | Anencephaly (HP:0002323) | 2.29234023 |
| 47 | Abnormality of T cells (HP:0002843) | 2.28108557 |
| 48 | Increased intramyocellular lipid droplets (HP:0012240) | 2.26333040 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.23660574 |
| 50 | Palpebral edema (HP:0100540) | 2.23151368 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.22360296 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.22360296 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.21893352 |
| 54 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20982493 |
| 55 | B lymphocytopenia (HP:0010976) | 2.20003142 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.19554490 |
| 57 | Gonadal dysgenesis (HP:0000133) | 2.19472527 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.19339458 |
| 59 | Spinal muscular atrophy (HP:0007269) | 2.18857413 |
| 60 | Type II lissencephaly (HP:0007260) | 2.17906437 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.14087712 |
| 62 | Duplicated collecting system (HP:0000081) | 2.13226246 |
| 63 | Abnormality of cochlea (HP:0000375) | 2.10234916 |
| 64 | Acute necrotizing encephalopathy (HP:0006965) | 2.09029259 |
| 65 | Hyponatremia (HP:0002902) | 2.08570218 |
| 66 | Trigonocephaly (HP:0000243) | 2.05523884 |
| 67 | Absent thumb (HP:0009777) | 2.01204620 |
| 68 | Cystic liver disease (HP:0006706) | 1.99287482 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 1.97784237 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 1.97101039 |
| 71 | Oligodactyly (hands) (HP:0001180) | 1.96783319 |
| 72 | Chronic diarrhea (HP:0002028) | 1.95633955 |
| 73 | Hypokalemic alkalosis (HP:0001949) | 1.92390188 |
| 74 | Acute encephalopathy (HP:0006846) | 1.91600533 |
| 75 | Hypertensive crisis (HP:0100735) | 1.90997416 |
| 76 | Large eyes (HP:0001090) | 1.89201747 |
| 77 | Amelogenesis imperfecta (HP:0000705) | 1.88551375 |
| 78 | Molar tooth sign on MRI (HP:0002419) | 1.88055160 |
| 79 | Abnormality of midbrain morphology (HP:0002418) | 1.88055160 |
| 80 | Postaxial foot polydactyly (HP:0001830) | 1.88041146 |
| 81 | IgM deficiency (HP:0002850) | 1.86847658 |
| 82 | Colon cancer (HP:0003003) | 1.82773008 |
| 83 | Neoplasm of the adrenal gland (HP:0100631) | 1.82273950 |
| 84 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81188119 |
| 85 | Eosinophilia (HP:0001880) | 1.81044784 |
| 86 | Birth length less than 3rd percentile (HP:0003561) | 1.80620560 |
| 87 | Hypoalbuminemia (HP:0003073) | 1.80075624 |
| 88 | Abnormal albumin level (HP:0012116) | 1.80075624 |
| 89 | Medial flaring of the eyebrow (HP:0010747) | 1.79406910 |
| 90 | Increased serum lactate (HP:0002151) | 1.79159819 |
| 91 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.78387182 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.77529689 |
| 93 | Male pseudohermaphroditism (HP:0000037) | 1.76752389 |
| 94 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76267835 |
| 95 | Neonatal respiratory distress (HP:0002643) | 1.76257663 |
| 96 | Progressive macrocephaly (HP:0004481) | 1.75801329 |
| 97 | Nephronophthisis (HP:0000090) | 1.75757332 |
| 98 | Pulmonary fibrosis (HP:0002206) | 1.74066992 |
| 99 | Furrowed tongue (HP:0000221) | 1.72717754 |
| 100 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.69419518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 8.35658892 |
| 2 | ZAK | 3.15567078 |
| 3 | CDC7 | 2.84468449 |
| 4 | MAP4K1 | 2.64391475 |
| 5 | FRK | 2.30645595 |
| 6 | VRK2 | 2.26318633 |
| 7 | CDK8 | 2.23880992 |
| 8 | TESK2 | 2.18255663 |
| 9 | MST4 | 1.95867960 |
| 10 | BCKDK | 1.94111026 |
| 11 | KDR | 1.82453675 |
| 12 | MAP4K2 | 1.81600494 |
| 13 | ITK | 1.80616898 |
| 14 | NME2 | 1.73830529 |
| 15 | TLK1 | 1.70251578 |
| 16 | BMPR1B | 1.64119706 |
| 17 | EIF2AK1 | 1.63103873 |
| 18 | GRK1 | 1.60315682 |
| 19 | PLK4 | 1.58752998 |
| 20 | GRK6 | 1.57893704 |
| 21 | PIK3CA | 1.48206746 |
| 22 | ADRBK2 | 1.41445547 |
| 23 | KIT | 1.31283700 |
| 24 | AURKB | 1.29382405 |
| 25 | BCR | 1.28647390 |
| 26 | MATK | 1.27438528 |
| 27 | ATR | 1.27283178 |
| 28 | FLT3 | 1.21767155 |
| 29 | TNK2 | 1.19878870 |
| 30 | VRK1 | 1.19720111 |
| 31 | EIF2AK3 | 1.14903895 |
| 32 | PLK3 | 1.13009640 |
| 33 | PRKCQ | 1.10773531 |
| 34 | MAPK15 | 1.09349098 |
| 35 | IKBKB | 1.09338108 |
| 36 | PASK | 1.09310082 |
| 37 | TIE1 | 1.08635650 |
| 38 | SYK | 1.08301854 |
| 39 | PLK2 | 1.01312862 |
| 40 | TEC | 0.97862654 |
| 41 | TGFBR1 | 0.95347200 |
| 42 | PRKCH | 0.92906996 |
| 43 | DYRK1B | 0.91449716 |
| 44 | ADRBK1 | 0.87888198 |
| 45 | MAPK13 | 0.86316306 |
| 46 | TXK | 0.84842087 |
| 47 | RIPK1 | 0.80939598 |
| 48 | PRKD3 | 0.80164498 |
| 49 | MAP2K2 | 0.78847823 |
| 50 | TTK | 0.78479506 |
| 51 | TSSK6 | 0.76182719 |
| 52 | NEK1 | 0.75732349 |
| 53 | LYN | 0.75650145 |
| 54 | WNK3 | 0.71241408 |
| 55 | CHEK2 | 0.68372348 |
| 56 | TBK1 | 0.68000277 |
| 57 | MAPK11 | 0.67986130 |
| 58 | WNK4 | 0.66883746 |
| 59 | LCK | 0.65717734 |
| 60 | CAMKK2 | 0.59822323 |
| 61 | GRK5 | 0.59682552 |
| 62 | BUB1 | 0.58615732 |
| 63 | PLK1 | 0.58487371 |
| 64 | CSNK2A1 | 0.58429170 |
| 65 | TYK2 | 0.58340303 |
| 66 | JAK3 | 0.57494993 |
| 67 | INSRR | 0.55277596 |
| 68 | MAPKAPK3 | 0.55193061 |
| 69 | IKBKE | 0.55112842 |
| 70 | RIPK4 | 0.55001429 |
| 71 | CSNK2A2 | 0.54652415 |
| 72 | TRPM7 | 0.54060856 |
| 73 | BTK | 0.52914947 |
| 74 | IRAK3 | 0.52772200 |
| 75 | ATM | 0.49042653 |
| 76 | BLK | 0.48995208 |
| 77 | NUAK1 | 0.48690915 |
| 78 | MAP3K8 | 0.47912982 |
| 79 | MKNK2 | 0.47528152 |
| 80 | DAPK2 | 0.46478885 |
| 81 | LRRK2 | 0.45301285 |
| 82 | PRKCA | 0.44970456 |
| 83 | OBSCN | 0.44670965 |
| 84 | MUSK | 0.43756243 |
| 85 | PRKCE | 0.43515549 |
| 86 | PBK | 0.42560059 |
| 87 | DAPK1 | 0.41197863 |
| 88 | STK10 | 0.41028616 |
| 89 | AURKA | 0.39694119 |
| 90 | TGFBR2 | 0.39515288 |
| 91 | CAMK2A | 0.37695620 |
| 92 | PIK3CG | 0.36729883 |
| 93 | RPS6KB2 | 0.36236458 |
| 94 | PRKCD | 0.35384080 |
| 95 | MAP3K13 | 0.33182731 |
| 96 | FGFR2 | 0.32697177 |
| 97 | FGFR1 | 0.32624075 |
| 98 | CSK | 0.32605967 |
| 99 | PRKACA | 0.32118915 |
| 100 | CDK4 | 0.31894299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 3.82399081 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.65255640 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.07857418 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.04015450 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.01857883 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.89912976 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.76897512 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.59943251 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.42469018 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.37678781 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.31742790 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.28170008 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.20037684 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15831296 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.14167977 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.10608630 |
| 17 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.96100533 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95317017 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.91938939 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91582369 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88637219 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.75968079 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65026724 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.63050516 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.52204741 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50739146 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46535990 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.45181898 |
| 29 | Huntingtons disease_Homo sapiens_hsa05016 | 1.44567037 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35668920 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.24781984 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14809385 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 1.14345939 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13305751 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09659272 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08438494 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06691867 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06157415 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.05536302 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95455658 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91769047 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90713772 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.88426571 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88062735 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87688625 |
| 46 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.87626752 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87533771 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87383479 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 0.85820916 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82066773 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80280317 |
| 52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.79068442 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75420170 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74009937 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73791607 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72606561 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72341487 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71531363 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71424677 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71136714 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70240998 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69699734 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69317350 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67077426 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66141031 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63363915 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62931061 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59848546 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59225540 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59040495 |
| 71 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57900481 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55908512 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.52366531 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50938695 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50796188 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48885394 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47562306 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47054069 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45658027 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44509260 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40650442 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40588666 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.38367266 |
| 84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38269335 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30323294 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28872011 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28572780 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.27056546 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25078059 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23194737 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22994554 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21973724 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.20939851 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.20188917 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20169435 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.19726823 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19692674 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18126652 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.16904886 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.16369228 |

